Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Research add new data to cancer therapy body of knowledge
February 8th, 2006
New findings from the United States and Japan describe advances in cancer therapy. Study 1: Dendritic cell therapy arrests carbonic anhydrase II activity in tumor vessels. "Tumor-associated antigens are promising candidates as target molecules for immunotherapy and a wide variety of tumor-associated antigens have been discovered through the presence of serum antibodies in cancer patients. We previously conducted dendritic cell therapy on 10 malignant melanoma patients and shrinkage or disappearance of metastatic tumors with massive necrosis occurred in two patients," researchers in Japan report. "In this study, we found a 29-kDa...
Source: Immunotherapy Weekly (2006-02-08)
|
